These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 15698586

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism.
    Bergenfelz A, Lindblom P, Lindergård B, Valdemarsson S, Westerdahl J.
    World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497
    [Abstract] [Full Text] [Related]

  • 4. In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
    Salusky IB, Goodman WG.
    Adv Nephrol Necker Hosp; 1996 Apr; 25():289-302. PubMed ID: 8717632
    [Abstract] [Full Text] [Related]

  • 5. Calcium regulation of parathyroid and C cell function in familial benign hypercalcemia.
    Rajala MM, Klee GG, Heath H.
    J Bone Miner Res; 1991 Feb; 6(2):117-24. PubMed ID: 2028833
    [Abstract] [Full Text] [Related]

  • 6. Parathyroid glands in calcium regulation and human disease.
    Akerström G, Hellman P, Hessman O, Segersten U, Westin G.
    Ann N Y Acad Sci; 2005 Apr; 1040():53-8. PubMed ID: 15891005
    [Abstract] [Full Text] [Related]

  • 7. Hyperparathyroidism.
    Tonini G, Tatò L, Rigon F, Radetti G, De Sanctis C, De Sanctis V, Buzi F, Bozzola M, Bona G, Bernasconi S.
    Minerva Pediatr; 2004 Feb; 56(1):125-31. PubMed ID: 15249924
    [Abstract] [Full Text] [Related]

  • 8. [Primary hyperparathyroidism: clinical and laboratory spectrum].
    Heilberg IP, Ramos OL, Schor N.
    Rev Paul Med; 1989 Feb; 107(4-6):212-8. PubMed ID: 2640506
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Primary hyperparathyroidism in pediatric patients.
    Kollars J, Zarroug AE, van Heerden J, Lteif A, Stavlo P, Suarez L, Moir C, Ishitani M, Rodeberg D.
    Pediatrics; 2005 Apr; 115(4):974-80. PubMed ID: 15805373
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Secondary causes of low bone mass in patients with breast cancer: a need for greater vigilance.
    Mann GB, Kang YC, Brand C, Ebeling PR, Miller JA.
    J Clin Oncol; 2009 Aug 01; 27(22):3605-10. PubMed ID: 19546403
    [Abstract] [Full Text] [Related]

  • 15. [Primary hyperparathyroidism].
    Carnevale V, Romagnoli E, Pipino M, Scillitani A, D'Erasmo E, Minisola S, Mazzuoli G.
    Clin Ter; 2005 Aug 01; 156(5):211-26. PubMed ID: 16382970
    [Abstract] [Full Text] [Related]

  • 16. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER, Kovacs KA, Jones G.
    Clin Endocrinol (Oxf); 2008 Dec 01; 69(6):855-63. PubMed ID: 18419790
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
    Brown AJ, Slatopolsky E.
    Nat Clin Pract Endocrinol Metab; 2007 Feb 01; 3(2):134-44. PubMed ID: 17237840
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.